Rowlandmiller & Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $103K | Sell |
|
|||||
|
2023
Q4 | $141K | Hold |
|
|||||
|
2023
Q3 | $140K | Hold |
|
|||||
|
2023
Q2 | $155K | Sell |
|
|||||
|
2023
Q1 | $177K | Sell |
|
|||||
|
2022
Q4 | $244K | Hold |
|
|||||
|
2022
Q3 | $239K | Hold |
|
|||||
|
2022
Q2 | $183K | Hold |
|
|||||
|
2022
Q1 | $189K | Hold |
|
|||||
|
2021
Q4 | $215K | Buy |
|
|||||
|
2021
Q3 | $178K | Sell |
|
|||||
|
2021
Q2 | $310K | Buy |
|
|||||
|
2021
Q1 | $220K | Hold |
|
|||||
|
2020
Q4 | $192K | Buy |
|
|||||
|
2020
Q3 | $211K | Hold |
|
|||||
|
2020
Q2 | $178K | Hold |
|
|||||
|
2020
Q1 | $211K | Buy |
|
|||||
|
2019
Q4 | $196K | Hold |
|
|||||
|
2019
Q3 | $154K | Hold |
|
|||||
|
2019
Q2 | $155K | Buy |
|
|||||
|
2019
Q1 | $127K | Hold |
|
|||||
|
2018
Q4 | $161K | Buy |
|
|||||
|
2018
Q3 | $179K | Hold |
|
|||||
|
2018
Q2 | $147K | Hold |
|
|||||
|
2018
Q1 | $139K | Hold |
|
|||||
|
2017
Q4 | $162K | Sell |
|
|||||
|
2017
Q3 | $375K | Buy |
|
|||||
|
2017
Q2 | $137K | Hold |
|
|||||
|
2017
Q1 | $138K | Hold |
|
|||||
|
2016
Q4 | $144K | Hold |
|
|||||
|
2016
Q3 | $158K | Hold |
|
|||||
|
2016
Q2 | $123K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $111K | Hold |
|
|||||
|
2015
Q3 | $110K | Hold |
|
|||||
|
2015
Q2 | $152K | Hold |
|
|||||
|
2015
Q1 | $155K | Hold |
|
|||||
|
2014
Q4 | $128K | Buy |
|